On June 5, 2023, Telesis Bio, Inc. closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.73 USD | -1.58% | -15.23% | -48.06% |
May. 09 | Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M | MT |
May. 09 | Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.06% | 6.38M | |
+4.79% | 217B | |
+7.13% | 191B | |
+28.02% | 154B | |
+32.95% | 112B | |
+1.29% | 62.75B | |
+16.75% | 53.34B | |
+0.94% | 48.88B | |
-3.44% | 39.36B | |
+3.00% | 35.73B |
- Stock Market
- Equities
- TBIO Stock
- News Telesis Bio, Inc.
- Telesis Bio, Inc. announced that it has received $28 million in funding from Novalis Capital Partners LLC, Northpond Ventures, LLC, BroadOak Capital Partners LLC, Investment Arm and another investor